Key result
Adenosine treatment successfully resolved supraventricular tachycardia in 95.8% of treated pediatric patients, though older children were more likely to respond to the first dose (p<0.05).
Why the study?
Supraventricular tachycardia is the most common pediatric arrhythmia, prompting the evaluation of adenosine dose, efficacy, and factors influencing treatment response in children.
Does adenosine effectively treat supraventricular tachycardia in pediatric patients, and what factors affect the response to the initial dose?
Population
30 patients aged 2-180 months with supraventricular tachycardia
Comparison
Patients responding to the first adenosine dose vs non-responders
Design
Retrospective study
Authors
Loading...
Supports adenosine efficacy in pediatric SVT; leaves open optimal age-specific initial dosing.
Cohort (n=30)
Does adenosine effectively treat supraventricular tachycardia in pediatric patients, and what factors affect the response to the initial dose?
Adenosine is highly effective for pediatric supraventricular tachycardia, though the standard initial dose of 0.1 mg/kg may be insufficient for children younger than one year.
Bıcılıoğlu et al. (2020) conducted a cohort in Supraventricular tachycardia (n=30). Adenosine was evaluated on Response to adenosine treatment. Adenosine treatment successfully resolved supraventricular tachycardia in 95.8% of treated pediatric patients, though older children were more likely to respond to the first dose (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: